Please login to the form below

Not currently logged in
Email:
Password:

Constella

This page shows the latest Constella news and features for those working in and with pharma, biotech and healthcare.

FDA approves Synergy's constipation drug Trulance

FDA approves Synergy's constipation drug Trulance

Plecanatide's closest competitor in the market is Ironwood/Allergan's Linzess/Constella (linaclotide), described as a guanylate cyclase stimulant, which is approved for the treatment of constipation-predominant IBS in

Latest news

  • PSI CRO expands clinical data management services

    Sly has previously worked for Aptiv Solutions, Constella Group and Origin Pharmaceuticals. .

  • News in brief, April 18, 2007

    OraSure added that it will partner with professional health services group, Constella, to provide vital counselling and referrals to consumers of the test. ... OraSure signed an agreement with Constella in early April 2007 to develop the counselling

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • PharmaLex Group strengthens development consulting team PharmaLex Group strengthens development consulting team

    She also brings experience from contract research organisation SRA International, where she was senior director and global head of regulatory affairs, and Constella Group, where she was head of strategic drug

  • Ironwood promotes Dr Mark Currie Ironwood promotes Dr Mark Currie

    Linaclotide was approved as a treatment for irritable bowel syndrome last year by regulators in Europe, where the drug is marketed as Constella by Almirall.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics